Does TRIAMCINOLONE Cause Type v hyperlipidaemia? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Type v hyperlipidaemia have been filed in association with TRIAMCINOLONE. This represents 0.1% of all adverse event reports for TRIAMCINOLONE.
7
Reports of Type v hyperlipidaemia with TRIAMCINOLONE
0.1%
of all TRIAMCINOLONE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From TRIAMCINOLONE?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TRIAMCINOLONE Cause?
Drug ineffective (3,035)
Psoriasis (1,131)
Off label use (901)
Product use in unapproved indication (724)
Condition aggravated (625)
Therapeutic product effect incomplete (624)
Treatment failure (612)
Drug intolerance (527)
Nausea (525)
Pruritus (485)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which TRIAMCINOLONE Alternatives Have Lower Type v hyperlipidaemia Risk?
TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE
TRIAMCINOLONE vs TRIAMTERENE
TRIAMCINOLONE vs TRIATEC
TRIAMCINOLONE vs TRIAZOLAM